$95M raised by Taysha for clinical trials of four new gene therapies
FierceBiotech - 05-Aug-2020Company has gathered support from investors to quickly lead therapies to clinic then market
Join the club for FREE to access the whole archive and other member benefits.
CEO, President at AveXis, Inc.
Sean Nolan, 51, is an accomplished senior executive with more than 28 years of biopharmaceutical experience. He served as Chief Executive Officer and President at AveXis, Inc.
Visit website: https://www.bloomberg.com/profile/person/16572099
See also: AveXis - Gene therapy company
Details last updated 12-Aug-2020
Company has gathered support from investors to quickly lead therapies to clinic then market